Our Real-World Evidence offerings turn diverse healthcare data into actionable insights, empowering confident decisions and better patient outcomes.


Systematic literature reviews of submissions to EMA, FDA, and HTA bodies can help overcome operational and methodological hurdles and mitigate regulatory risk. While FDA and EMA online databases facilitate document retrieval, acquiring key documents from disparate HTA bodies can be complex.
Read this case study to learn how IQVIA's platforms and capabilities, including Natural Language Processing (NLP) and Instant Translation Platform enables a side-by-side comparison of regulatory and HTA feedback, leading to actionable insights and significant time-savings.
Our Real-World Evidence offerings turn diverse healthcare data into actionable insights, empowering confident decisions and better patient outcomes.